FDA Issues Framework For Use Of Digital Health Technologies In Drug Development
Executive Summary
The FDA’s new framework for the use of digital health technologies will engage stakeholders to provide more guidelines for the industry.
You may also be interested in...
Digital Health Roundup: Voice Biomarkers; SXSW, LSI, ACC; FTC BetterHelp Settlement
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses conference highlights from SXSW and LSI while Barnaby Pickering talks about his coverage on voice biomarkers. Hannah Daniel discusses BetterHelp’s return of $7.8m to customers to settle with FTC for sharing health data.
What Can Tech Companies Teach Us About Clinical Trials?
Collaboration between tech companies and medical researchers may be the answer to modernizing clinical trials.
Office of Digital Transformation’s 2022 Year In Review: The MAP To Success
The FDA’s Office of Digital Transformation published its first full-year report summarizing its 2022 accomplishments and future strategic priorities.